Home / Italy / AGC Biologics SPA
AGC Biologics SPA
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
37 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
July 22, 2013 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 28, 2017 | Oxford Asset Management | 0.49% | still open |
| April 24, 2017 | Oxford Asset Management | 0.51% | still open |
| March 17, 2017 | Oxford Asset Management | 0.49% | still open |
| December 21, 2016 | Oxford Asset Management | 0.59% | still open |
| November 10, 2016 | Citadel Advisors II LLC | 0.49% | still open |
| November 7, 2016 | Oxford Asset Management | 0.61% | still open |
| November 7, 2016 | Citadel Advisors II LLC | 0.59% | still open |
| November 4, 2016 | Citadel Advisors II LLC | 0.74% | still open |
| November 3, 2016 | Citadel Advisors II LLC | 0.88% | still open |
| November 2, 2016 | Citadel Advisors II LLC | 1.00% | still open |
| November 1, 2016 | Citadel Advisors II LLC | 1.13% | still open |
| October 31, 2016 | Citadel Advisors II LLC | 0.99% | still open |
| October 28, 2016 | Citadel Advisors II LLC | 0.80% | still open |
| October 28, 2016 | Oxford Asset Management | 0.55% | still open |
| October 27, 2016 | Citadel Advisors II LLC | 0.63% | still open |
| October 26, 2016 | Citadel Advisors II LLC | 0.50% | still open |
| November 13, 2015 | GSA Capital Partners LLP | 0.49% | still open |
| November 3, 2015 | GSA Capital Partners LLP | 0.59% | still open |
| October 21, 2015 | GSA Capital Partners LLP | 0.68% | still open |
| September 10, 2015 | GSA Capital Partners LLP | 0.70% | still open |
| August 10, 2015 | GSA Capital Partners LLP | 0.60% | still open |
| July 22, 2015 | GSA Capital Partners LLP | 0.50% | still open |
| March 13, 2015 | GSA Capital Partners LLP | 0.47% | still open |
| March 12, 2015 | GSA Capital Partners LLP | 0.60% | still open |
| December 11, 2014 | GSA Capital Partners LLP | 0.70% | still open |
| August 28, 2014 | GSA Capital Partners LLP | 0.61% | still open |
| August 6, 2014 | GSA Capital Partners LLP | 0.50% | still open |
| March 28, 2014 | GSA Capital Partners LLP | 0.45% | still open |
| February 12, 2014 | GSA Capital Partners LLP | 0.59% | still open |
| November 18, 2013 | GSA Capital Partners LLP | 0.68% | still open |
| November 15, 2013 | GSA Capital Partners LLP | 0.70% | still open |
| November 12, 2013 | GSA Capital Partners LLP | 0.69% | still open |
| October 11, 2013 | GSA Capital Partners LLP | 0.79% | still open |
| September 2, 2013 | GSA Capital Partners LLP | 0.80% | still open |
| August 19, 2013 | GSA Capital Partners LLP | 0.72% | still open |
| July 26, 2013 | GSA Capital Partners LLP | 0.61% | still open |
| July 22, 2013 | GSA Capital Partners LLP | 0.50% | still open |
Other companies sold short in Italy
- Saipem SPA 14.94% of the capital sold short
- Avio SPA 7.70% of the capital sold short
- DoVALUE SPA 5.99% of the capital sold short
- BFF Bank SPA 5.90% of the capital sold short
- Stellantis NV 5.18% of the capital sold short
- Banca Ifis SPA 4.26% of the capital sold short
- Nexi SPA 3.88% of the capital sold short
- Sanlorenzo SPA 3.30% of the capital sold short
- Moncler SPA 2.78% of the capital sold short
- Amplifon SPA 2.73% of the capital sold short
- Fincantieri SPA 2.71% of the capital sold short
- Trevi - Finanziaria Industriale SPA 2.59% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, AGC Biologics SPA, source Consob, data as at November 28, 2017, https://www.quivad.com/action/agc-biologics-spa